EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Emerging risk factors and the role of gut microbiota in immunomodulation and therapeutic implications in colorectal cancer

Sonakshi Modeel, Sneha Siwach, Padma Dolkar, Meenu Chaurasia, Pankaj Yadav, Apoorva Atri, Aarzoo Yadav, Tarana Negi, Ram Krishan Negi

Cancer Pathogenesis and Therapy · 2026-01 · 4 (1) · 14-30

DOI: 10.1016/j.cpt.2025.06.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Pathogenesis and Therapy, 2026-01. Verfasst von Sonakshi Modeel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fish Molecular Biology Lab, Department of Zoology, University of Delhi, North Campus, Delhi, 110007, India. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pathophysiology of many ailments, including neurological, gastrointestinal, and metabolic problems, is well known to be influenced by intestinal dysbiosis. Clinical research has provided evidence suggesting a strong correlation between dysbiosis of the gut microbiome and colorectal cancer (CRC) development. The active reprogramming of metabolic pathways to boost glycolysis, fatty acid production, lipogenesis, and glutaminolysis constitutes a major metabolic shift in cancer development, including CRC. The complex combination of different factors leads to CRC, making it an environmental disease. These factors include food and lifestyle choices, genetics and family history, age, underlying intestinal diseases, and dysbiosis of the gut microbiota. One of the primary risk factors for carcinoma development is diet, which impacts an individual's gut microbiome. In addition to impacting CRC formation, the gut microbiome also has immunomodulatory effects, including various immunological interactions and the underlying mechanisms governing them. Microbial interactions in CRC have been extensively studied, yet numerous unresolved queries exist on how gut bacteria can influence treatment. It is possible to perform microbiome-driven immunotherapies focusing on probiotics, prebiotics, and synbiotics. However, large-scale treatment utilization in CRC patients is limited by several issues, including variations in the microbial makeup of each patient's gut and a lack of established methods. The study highlights the impact of several risk factors, including dysbiosis of the gut microbiome and different approaches to halting and treating CRC progression with a focus on diet changes and modulation of the gut flora. Given the foregoing, we propose that if research gaps are addressed and immunotherapy is paired with microbial interventions, microbiota-based therapeutics could potentially impede the growth of tumors and treat CRC.

Schlagwörter

Stichwörter der Autor:innen

CRC therapyColorectal cancerGastrointestinal microbiomeImmunomodulationProbioticsRisk factors

Autor:innen und Institutionen

  • Fish Molecular Biology Lab, Department of Zoology, University of Delhi, North Campus, Delhi, 110007, India.
  • Government College, Kharkhoda, District Sonipat, Haryana, 124102, India.

Förderung

  • Science and Engineering Research Board

Zitieren

APA

Modeel, S., Siwach, S., Dolkar, P., Chaurasia, M., Yadav, P., Atri, A., Yadav, A., Negi, T., & Negi, R. K. (2026). Emerging risk factors and the role of gut microbiota in immunomodulation and therapeutic implications in colorectal cancer. Cancer Pathogenesis and Therapy, 4(1), 14-30. https://doi.org/10.1016/j.cpt.2025.06.007

Vancouver

Modeel S, Siwach S, Dolkar P, Chaurasia M, Yadav P, Atri A, et al. Emerging risk factors and the role of gut microbiota in immunomodulation and therapeutic implications in colorectal cancer. Cancer Pathogenesis and Therapy. 2026;4(1):14-30. doi:10.1016/j.cpt.2025.06.007

BibTeX
@article{Modeel2026,
  author = {Modeel, Sonakshi and Siwach, Sneha and Dolkar, Padma and Chaurasia, Meenu and Yadav, Pankaj and Atri, Apoorva and Yadav, Aarzoo and Negi, Tarana and Negi, Ram Krishan},
  title = {Emerging risk factors and the role of gut microbiota in immunomodulation and therapeutic implications in colorectal cancer},
  journal = {Cancer Pathogenesis and Therapy},
  year = {2026},
  volume = {4},
  number = {1},
  pages = {14--30},
  doi = {10.1016/j.cpt.2025.06.007}
}
Kostenlos starten →